Biotech News

Home Biotech News

No posts to display

APPLE

PharmaCyte Biotech Announces Submission of Drug Master File to FDA for...

Andrew M. - July 27, 2020

Biotech News

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell...

Cardiol Therapeutics’ Cortalex™ CBD Now Available Exclusively Online at Medical Cannabis by Shoppers Inc.

Paul Archie - October 20, 2020

FDA Approves Landmark COVID/Heart/CBD Clinical Trial

Paul Archie - September 30, 2020

Cardiol Therapeutics Receives FDA Approval For Investigational New Drug (IND) Application For Phase II/III...

Paul Archie - September 25, 2020

Therma Bright Provides Corporate Update on the Saringer and Orpheus Transactions

Andrew M. - August 20, 2020

BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.

BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).

BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate

Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials

Innovus Pharmaceuticals Continues Strong Revenue Growth & New Product Rollouts

Biotech News

No posts to display

APPLE

PharmaCyte Biotech Announces Submission of Drug Master File to FDA for...

RECENT POSTS

Cardiol Therapeutics’ Cortalex™ CBD Now Available Exclusively Online at Medical Cannabis by Shoppers Inc.

FDA Approves Landmark COVID/Heart/CBD Clinical Trial

Cardiol Therapeutics Receives FDA Approval For Investigational New Drug (IND) Application For Phase II/III...

Therma Bright Provides Corporate Update on the Saringer and Orpheus Transactions

EVEN MORE NEWS

Cardiol Therapeutics’ Cortalex™ CBD Now Available Exclusively Online at Medical Cannabis...

FDA Approves Landmark COVID/Heart/CBD Clinical Trial

Cardiol Therapeutics Receives FDA Approval For Investigational New Drug (IND) Application...

POPULAR CATEGORY